Canopy Growth Announces Results of Annual General and Special Shareholder Meeting

$CGC
Medicinal Chemicals and Botanical Products
Health Care
Get the next $CGC alert in real time by email

SMITHS FALLS, ON, Sept. 16, 2022 /PRNewswire/ - Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) ("Canopy Growth" or the "Company") today announced the voting results from its annual general and special meeting of shareholders held on September 15, 2022 (the "Meeting").

A total of 256,426,802 common shares of the Company, representing 53.42% of the issued and outstanding common shares of the Company, were voted in connection with the Meeting by shareholders and proxy holders.

All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated July 28, 2022 (the "Proxy Statement"), were approved by the requisite majority of votes cast at the Meeting, as further detailed below.

Each of the directors listed as a nominee in the Proxy Statement was elected at the Meeting to serve as a director of the Company until the Company's next annual shareholders meeting or until his or her successor is duly elected or appointed. The detailed results of the vote for the election of directors held at the Meeting are set out below:

Name of Nominee     

Votes cast

FOR                 

% Votes

FOR                

Votes

AGAINST

% Votes

AGAINST

Judy A. Schmeling

174,936,094

96.66 %

6,040,153

3.34 %

David Klein

172,965,207

95.57 %

8,011,041

4.43 %

Garth Hankinson

173,043,911

95.62 %

7,932,337

4.38 %

Robert L. Hanson

169,930,747

93.91 %

11,028,826

6.09 %

David Lazzarato

174,853,021

96.62 %

6,123,027

3.38 %

James A. Sabia

171,154,369

94.57 %

9,821,879

5.43 %

Theresa Yanofsky

170,590,929

94.26 %

10,385,319

5.74 %

Canopy Growth shareholders also approved the re-appointment of KPMG LLP as the Company's auditors for the 2023 fiscal year and authorized the board of directors to fix its remuneration.

In addition, Canopy Growth shareholders approved the renewal of the Company's Employee Stock Purchase Plan.

Canopy Growth shareholders also approved an advisory (non-binding) resolution on the compensation of the Company's named executive officers.

For complete results on all matters voted on at the Meeting, please consult the Company's Report of Voting Results which will be filed on the Company's SEDAR profile at www.sedar.com, and the Company's Form 8-K which will be filed on EDGAR at www.sec.gov/edgar.

About Canopy Growth Corporation

Canopy Growth (TSX:WEED, NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions, and has introduced additional hemp-derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information, visit www.canopygrowth.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/canopy-growth-announces-results-of-annual-general-and-special-shareholder-meeting-301625998.html

SOURCE Canopy Growth Corporation

Get the next $CGC alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CGC

DatePrice TargetRatingAnalyst
4/4/2023Underperform → Mkt Perform
Bernstein
11/2/2022$1.50Underperform
Bernstein
10/26/2022Sell → Hold
Canaccord Genuity
6/8/2022Market Perform → Underperform
BMO Capital Markets
3/22/2022Equal Weight → Underweight
Barclays
3/1/2022$14.00 → $9.00Equal-Weight
Barclays
2/18/2022$9.60 → $11.00Neutral
Cantor Fitzgerald
12/22/2021Neutral → Underperform
BofA Securities
More analyst ratings

$CGC
Press Releases

Fastest customizable press release news feed in the world

See more
  • Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand

    New Brand Features Premium Genetics, Selected for Potency, Terpenes, and Consistency Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched Spectrum Reserve, a new premium medical cannabis brand in Canada. Designed to meet the evolving needs of medical cannabis patients, Spectrum Reserve represents the peak of cannabis cultivation – featuring flower selected for size, potency, and terpene levels through rigorous in-house standards during cultivation and post-harvest. Under this new program, Spectrum Reserve is expected to introduce new strains on a r

    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
  • Canopy Growth Strengthens Balance Sheet with Optional Early Prepayment to Reduce Term Loan by US$100 Million

    Early Prepayment Reduces Annual Interest Expense by US$13 Million, Extends Maturity of Term Loan to September 2027 This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated June 6, 2024 to its short form base shelf prospectus dated February 28, 2025 Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that it has made an optional early prepayment under its senior secured term loan (the "Term Loan") in an aggregate principal amount equal to US$100 million at a discounted price of US

    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
  • Wana Brands Brings Hemp-Derived THC Edibles to Texas

    BOULDER, Colo., March 17, 2025 /PRNewswire/ -- Wana Brands, North America's leading edibles provider and a subsidiary of Canopy USA LLC ("Canopy USA"), is thrilled to announce the launch of its hemp-derived Delta-9 THC gummies in Texas, marking the 22nd state where Wana gummies are available. This strategic expansion underscores Wana's commitment to delivering safe, reliable cannabis products that empower consumers to take control of their plant-powered wellness journey. "Wana's expansion into Texas comes at a pivotal time as the state's cannabis landscape continues to evolve,

    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

$CGC
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$CGC
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$CGC
SEC Filings

See more

$CGC
Leadership Updates

Live Leadership Updates

See more
  • Canopy USA Announces Appointment of Mr. M. Brooks Jorgensen as President

    A cannabis and beverage alcohol industry executive with more than 25 years of experience, Mr. Jorgensen will lead the unified Canopy USA organization forward with a focus on driving profitable growth across the U.S. With the completed acquisitions of Acreage, Wana, and Jetty, Canopy USA now enters a new chapter of growth across key segments including flower, edibles, vapes, extracts, and through an established retail presence in high potential markets across the Midwest and Northeast BOULDER, Colo., January 6, 2025 /PRNewswire/ - Canopy USA, LLC ("Canopy USA"), a brand-driven organization strategically positioned across the fastest growing states and highest potential segments of the U.S. c

    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
  • Canopy Growth Announces Results of Annual General Meeting

    SMITHS FALLS, ON, Sept. 25, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) is pleased to announce today the voting results from its annual general meeting of shareholders held on September 24, 2024 (the "Meeting"). All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated August 1, 2024 (the "Proxy Statement"), were approved by the requisite number of votes cast at the Meeting, as further detailed below. Each of the direc

    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
  • Canopy Growth Announces Extension of Proxy Voting Deadline for Upcoming Annual General Meeting

    Shareholders now have until September 24, 2024 at 9:00 a.m. (Eastern Time) to submit votes to help ensure a quorum is achieved Your Vote is Important! If you need assistance with voting your shares please contact Laurel Hill Advisory Group at 1-877-452-7184 or by e-mail at assistance@laurelhill.com SMITHS FALLS, ON, Sept. 20, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) announced today that it has extended the deadline for the submission of proxies related to its upcoming annual general meeting of shareholders (the "Meeting") to September 24, 2024 at 9:00 a.m. (Eastern time). The Meeting will be held later the same day, at 1:00 p.m.

    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

$CGC
Financials

Live finance-specific insights

See more
  • The Week in Canadian Press Releases: 10 Stories You Need to See

    A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, Feb. 14, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that

    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
  • Canopy Growth Reports Third Quarter Fiscal Year 2025 Financial Results

    Strong holiday sales drove Storz & Bickel net revenue growth of 19% year-over-year   Record quarter for Canada medical cannabis with net revenue increasing 16%; international markets cannabis net revenue grew 14% year-over-year    Successfully launched Claybourne infused pre-rolls across Canada, Claybourne rose to #3 market share in the infused pre-roll category in British Columbia and Ontario after 6 weeks in market1 SMITHS FALLS, ON, Feb. 7, 2025 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announces its financial results for the third fiscal quarter ended December 31, 2024 ("Q3 FY2025"). All financial information in this press

    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care
  • Canopy Growth to Report Third Quarter Fiscal 2025 Financial Results on February 7, 2025

    SMITHS FALLS, ON, Jan. 24, 2025 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) will release its financial results for the third quarter fiscal year 2025 ended December 31, 2024 before financial markets open on February 7, 2025. Following the release of its third quarter fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Judy Hong, CFO on February 7 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://app.webinar.net/yY1K7LrWq9O

    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

$CGC
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more